xenin-25
Peptideexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00798915)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GIP agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xenin
- xenin
- xenin
- xenin 25
- xenin-25
- xenin-25
- xenin-25
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02204813 | Phase 1 | Jul 1, 2014 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Washington University in St. Louis |
| NCT01951729 | Phase 1 | Mar 13, 2013 | American Diabetes Association, Washington University in St. Louis |
| NCT01951716 | Phase 1 | Jan 1, 2013 | American Diabetes Association, Washington University in St. Louis |
| NCT00949663 | Phase 1 | Oct 1, 2009 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Washington University in St. Louis |
| NCT00798915 | Phase 1 | Dec 1, 2008 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Washington University in St. Louis |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 5 | 5 | 1 | 2008 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 3 | 0 | 1 | 2008 |
| American Diabetes Association | Academic/Hospital | 2 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1